Abstract:Objective To investigate the inhibiting effects of vitamin receptor agonist - parlicalcitol on the inflammatory reaction of kidney tissue in diabetic nephropathy mice by exploiting the db/ db mouse model of type 2 diabetic nephropathy. Methods From January to November in 2015,under the method of random number table,we divided the 60 male five - week C57BLKS/ J db/ db mice of SPF level into three groups:db/ db - control group( N group,n = 20),db/ db -dimethyl sulfoxide group(D group,n = 20),and db/ db - paricalcitol group(P group,n = 20),and we enrolled db/ m mice of littermate as the normal control group(C group,n = 20). At the age of 10 weeks,mice in P group were given intraperitoneal injection of paricalcitol at a dose of 0. 3 μg/ kg qod,the same amount of dimethyl sulfoxide as P group plus 0. 9% sodium chloride solution were injected into D group,N and C group were not intervened. After 12 - week intervention,we measured the body mass index,the fasting blood - glucose,24 - hour urine protein quantitation;we retained the kidney tissue to make a renal histopathological examination. The expression of real - time fluorescent quantitative PCR, Western blotting, and immunohistochemical detection of inflammatory factor interleukin( IL) - 6,and tumor necrosis factor - α( TNF-α) mRNA and the protein expression levels were applied. Results After 12 - week medical intervention,the comparison of body mass, fasting blood - glucose,and the 24 - hour urine protein quantitation in the four groups showed significant differences( P <0. 01);the body mass,fasting blood - glucose,the 24 - hour urine protein quantitation of N group,D group and P group were higher than those of C group,the 24 - hour urine protein quantitation of P group was lower than that of N group and D group(P< 0. 05). Pathological examination showed that the structure of the glomerulus and the renal tubular of C group was complete and clear;while there was partially inflammatory cell infiltration in renal tubulointerstitial in subjects of N group and D group,the inflammatory reaction was evident compared with C group;compared with N group and D group,the renal pathologic changes of P group reduced,and the inflammatory reaction alleviated. The IL-6,TNF-α mRNA and the protein expression level of the four groups were significantly different(P < 0. 01);the expression levels of IL-6,TNF-α mRNA and protein of N group,D group and P group were all higher than those of C group,and the expression levels of IL-6,TNF-α mRNA and protein of P group were lower than those of N group and D group(P < 0. 05). Immunohistochemical results showed that compared with C group,the renal tissue expression of IL-6,TNF-α of N group and D group increased,and those of P group decreased compared with N group and D group. Conclusion Paricalcitol can alleviate the inflammatory reaction in diabetic nephropathy mice kidney tissue,and the effect may not rely on reducing blood glucose.

Enhanced renoprotective actions of Paricalcitol and omega-3 fatty acids co-therapy against diabetic nephropathy in rat

Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats

Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus

Reaction of Paricalcitol Inhibition on Kidney Tissue Inflammation in Mice with Diabetic Nephropathy

Paricalcitol ameliorates diabetic nephropathy by promoting EETs and M2 macrophage polarization and inhibiting inflammation by regulating VDR/CYP2J2 axis

The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model

An effect of combination of resveratrol with vitamin D3 on modulation of proinflammatory cytokines in diabetic nephropathy induces rat

Mitigating diabetes-related complications: Empowering metformin with cholecalciferol and taurine supplementation in type 2 diabetic rats

Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance

Paricalcitol Ameliorates Acute Kidney Injury in Mice by Suppressing Oxidative Stress and Inflammation via Nrf2/HO-1 Signaling

Combination Of Ginsenoside Rg1 And Astragaloside Iv Reduces Oxidative Stress And Inhibits Tgf-Beta 1/Smads Signaling Cascade On Renal Fibrosis In Rats With Diabetic Nephropathy

Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy

Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease

Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease

Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy

The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.

MG132 enhances the renal anti-oxidative ability in diabetic nephropathy rats

The effects of calcitriol on ameliorating podocytes impairment and its possible mechanism in DN rats

Paricalcitol prevents MAPK pathway activation and inflammation in adriamycin-induced kidney injury in rats

A Low-Dose Combination of Valsartan and Low Molecular Weight Heparin Better Improved Glomerular Permeability Than Did High-Dose Monotherapy in Rats with Diabetic Nephropathy.

Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation